(ENOR) iShares MSCI Norway - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B4995 • Miscellaneous Region
ENOR: Securities, Stocks, Equity, Norway Market, Capitalization-Weighted
The iShares MSCI Norway ETF (BATS:ENOR) is designed to track the performance of the MSCI Norway Index, a free float-adjusted, market capitalization-weighted index that captures the large-, mid-, and small-cap segments of the Norwegian equity market. The fund typically invests at least 80% of its assets in securities from the underlying index or in investments with similar economic characteristics. This approach allows the ETF to closely replicate the indexs performance while maintaining flexibility in its investment strategy. As a non-diversified fund, ENOR can concentrate its holdings in a smaller number of securities, which may amplify both returns and risks. The fund is listed on the BATS exchange and is categorized under Miscellaneous Region ETFs.
From a technical standpoint, ENOR has shown recent strength, with its last price of $24.72 exceeding its 20-day and 50-day simple moving averages (SMAs) of $23.90 and $23.48, respectively. However, it remains slightly below its 200-day SMA of $23.61, indicating some longer-term instability. The average true range (ATR) of 0.26 suggests relatively low volatility, while the average 20-day volume of 6,926 shares reflects modest trading activity. Fundamentally, the ETF manages assets under management (AUM) of $28.80 million, which is moderate for a country-specific ETF but sufficient to ensure liquidity and operational efficiency.
3-Month Forecast (Based on Technical and Fundamental Data):Over the next three months, ENOR is likely to experience low volatility, as indicated by its ATR of 0.26. The funds recent price movement above its 20-day and 50-day SMAs suggests potential short-term upside, though its position below the 200-day SMA may signal longer-term challenges. With moderate AUM and average daily trading volume, price movements could be influenced by shifts in global sentiment toward Norwegian equities, particularly in the energy and financial sectors, which are heavily represented in the MSCI Norway Index. Overall, the forecast is neutral with a slight positive bias, contingent on broader market conditions and Norways macroeconomic environment.
Additional Sources for ENOR ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ENOR ETF Overview
Market Cap in USD | 36m |
Category | Miscellaneous Region |
TER | 0.53% |
IPO / Inception | 2012-01-23 |
ENOR ETF Ratings
Growth Rating | 35.1 |
Fundamental | - |
Dividend Rating | 76.8 |
Rel. Strength | 1.13 |
Analysts | - |
Fair Price Momentum | 25.25 USD |
Fair Price DCF | - |
ENOR Dividends
Dividend Yield 12m | 5.72% |
Yield on Cost 5y | 9.99% |
Annual Growth 5y | 18.81% |
Payout Consistency | 81.8% |
ENOR Growth Ratios
Growth Correlation 3m | 50.9% |
Growth Correlation 12m | 19.4% |
Growth Correlation 5y | 21.9% |
CAGR 5y | 12.70% |
CAGR/Max DD 5y | 0.39 |
Sharpe Ratio 12m | 1.72 |
Alpha | 3.07 |
Beta | 0.718 |
Volatility | 24.15% |
Current Volume | 13.2k |
Average Volume 20d | 12k |
As of May 10, 2025, the stock is trading at USD 25.83 with a total of 13,170 shares traded.
Over the past week, the price has changed by +1.53%, over one month by +16.94%, over three months by +8.35% and over the past year by +11.90%.
Partly, yes. Based on ValueRay Analyses, iShares MSCI Norway (BATS:ENOR) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 35.13 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENOR as of May 2025 is 25.25. This means that ENOR is currently overvalued and has a potential downside of -2.25%.
iShares MSCI Norway has no consensus analysts rating.
According to ValueRays Forecast Model, ENOR iShares MSCI Norway will be worth about 28.2 in May 2026. The stock is currently trading at 25.83. This means that the stock has a potential upside of +9.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.2 | 9.2% |